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Abstract: Endocrine dysfunction is a common effect of traumatic brain injury (TBI). In 
addition to affecting the regulation of important body functions, the disruption of 
endocrine physiology can significantly impair mental functions, such as attention, memory, 
executive function, and mood. This mini-review focuses on alterations in mental 
functioning that are associated with neuroendocrine disturbances in adults who suffered 
TBI. It summarizes the contribution of hormones to the regulation of mental functions, the 
consequences of TBI on mental health and neuroendocrine homeostasis, and the effects of 
hormone substitution on mental dysfunction caused by TBI. The available empirical 
evidence suggests that comprehensive assessment of mental functions should be standard 
in TBI subjects presenting with hormone deficiency and that hormone replacement therapy 
should be accompanied by pre- and post-assessments. 




TBI represents one of the leading causes of cognitive, emotional, and motor disability in both, 
industrialized and non-industrialized countries; falls, road, occupational and recreational accidents, and 
violence are the most frequent causes of TBI [1]. 
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Functional impairments after brain injury are usually explained in terms of morphological and 
pathophysiological alterations of cortical and subcortical brain structures. This view is consistent with 
the fact that injury to local and distributed components of brain networks, and their interplay, can alter 
cognition, affect, and behavior [2]. While functional impairments after acquired brain injury are 
sequelae of grey (cortex) and white matter (subcortical fiber connections), endocrine hormones also 
play an essential role in maintaining brain function, including cognitive performance and the 
regulation of motivation/intention and emotion [3]. The most commonly reported cognitive deficits in 
moderate and severe TBI include impaired processing speed (“cognitive slowing”), which can affect 
practically all other cognitive domains, difficulties with concentration (elevated distractibility), and 
divided attention (decreased multi-tasking), memory, and executive function. Residual cognitive 
deficits may persist and may interfere with returning to or gaining employment and independent living. 
Reduced information processing speed and difficulties with concentration and divided attention are the 
most common deficits in mild TBI (for a review, see [4]). The risk for psychopathological 
symptomatology does not depend on TBI severity [5]; conditions such as major depression  
(~14%–42%), posttraumatic stress disorder (PTSD; ~14%), anxiety disorders (~9%), and bipolar 
disorders (~4%) can occur and persist after TBI [6]. Both, diffuse and focal lesions following TBI can 
explain cognitive and psychopathological alterations. Diffuse axonal injury may cause more global 
cognitive dysfunction, for example, reduced information processing and mental speed, sustained 
attention, concentration and divided attention, whereas focal injury (e.g., contusion) causes deficits 
that are more specific. Frontal and temporal contusions are common in TBI, and are responsible for 
memory and executive dysfunction, but they may also influence affect. Furthermore, vascular 
compromise and edema can disrupt blood supply and oxygen delivery to tissues, thus contributing to 
neuropsychological deficits; the latter vary according to the site of injury. Thus, TBI may be seen as a 
more “generalized” brain injury, causing nonspecific functional impairments, e.g., cognitive slowing; 
more specific functional deficits in the domains of attention, memory and executive function result 
from focal injury to grey and white matter contusion or traumatic complications [7,8]. 
This mini-review focuses on alterations in mental functioning (cognition, mood) that are associated 
with neuroendocrine disturbances in adults who have suffered traumatic brain injury (TBI); it also 
considers the role of hormones in brain plasticity. Specifically, the article will address the following 
issues: (a) hormonal contributions to the regulation of certain mental functions; (b) the consequences 
of TBI on mental health and neuroendocrine homeostasis; and (c) the effects of hormone replacement 
on mental dysfunction caused by TBI. Our review of the available empirical evidence suggests that 
improvements in the identification and management of hormone deficiencies in TBI subjects requires 
the inclusion of comprehensive, standardized neuropsychological assessment; this will help better 
understand and explain functional impairments in TBI. 
2. Hormones and Mental Functions 
Abundant evidence in humans and animals points to the important role of the endocrine system in 
brain development and the regulation of cognitive, emotional, affective, motivational, and social 
behaviors; endocrine hormones also regulate behaviors that are essential for individual and species 
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survival (sleep, appetite, thirst, reproductive). Space restrictions allow us to illustrate this by just a few 
examples that represent the different classes of endocrine secretions. 
A large array of peptides of cerebral origin (e.g., thyrotropin-releasing hormone, growth  
hormone-releasing hormone, corticotrophin-releasing hormone, arginine vasopressin, oxytocin), best 
known for their role in the regulation of the peripheral endocrine tissues, exert direct (intracerebral) or 
indirect effects on cognition and mood [3]. The pituitary polypeptide hormone growth hormone, better 
known as key regulator of somatic growth and metabolism, is essential for normal brain development 
as well as cognitive function such as memory [9–11]. Insulin, another polypeptide, appears to be 
essential for optimal functioning of various cortical and subcortical structures, in particular the 
hippocampus and prefrontal cortex. In light of the role of insulin in regulating blood glucose levels, it 
is interesting that, hyper- and hypoglycemic states are frequently accompanied by affective symptoms 
and impaired cognitive performance [12–14]. 
Low-molecular weight non-peptidergic hormones produced in the periphery also exert strong 
effects on brain functions. These hormones (e.g., gonadal steroids, such as estrogen and testosterone, 
adrenal steroids, such a cortisol) pass across the blood-brain barrier because of their relative 
lipophilicity or through binding to specific transporters (e.g., thyroid hormones). All of them can elicit 
long-lasting effects in the brain by binding to receptors that are ligand-activated transcription factors. 
Receptors for each of these classes of hormone are present in diverse brain regions and, are especially 
abundant in corticolimbic structures as well as the hypothalamus. Although primarily implicated in 
thermogenic processes, thyroid hormones (e.g., tri-iodothyronine and thyroxine) are crucial for the maturation 
of neural cells and are essential for learning and memory and overall cognitive performance [15,16].  
Hyper- and hypothyroid states are associated with reduced executive function [17] and 
hyperthyroidism may cause irritability, restlessness, hyperexcitability, and emotional instability [18]. 
Sex steroids, in particular 17β-estradiol, play an important role in sexual differentiation of the brain 
and expression of sex-specific cognitive and affective behaviors [19]; they also enhance cognition, in 
particular memory [20]. Glucocorticoids (GC, e.g., cortisol), are released from the adrenal glands as 
part of the adaptive response to stress; as their name indicates, their main function is to regulate 
glucose and lipid metabolism [21]. In addition, glucocorticoids are potent suppressors of the immune 
response. Persistently high GC levels, such as those found under conditions of chronic stress, disrupt 
homeostasis (e.g., cardiovascular, metabolic) and may lead to the development of psychopathological 
symptoms such as depression [22]. In addition, GC influences cognition (e.g., attention, and visual and 
verbal memory) in a U-shaped dose-related manner [21,23]. It is, thus, not surprising that many 
subjects with major depression present with cognitive impairments. Neuropsychological studies 
revealed that hypercortisolism is more strongly associated with superordinate executive dysfunction 
rather than specific memory deficits [24]. This finding is in line with high expression levels of 
glucocorticoid receptors in the prefrontal cortex, hippocampus, amygdala, thalamus, and  
hypothalamus [25]. Thyroid hormones, and the above-mentioned sex and adrenal steroids all 
participate in the birth, differentiation and survival of neurons and/or glial cells. In addition, 
progesterone, a steroid produced by both the ovaries and brain, appears to influence neuronal repair 
and survival; the latter actions have been ascribed to progesterone derivatives (the so-called 
neurosteroids) that modulate the electrophysiological activity of neurons by binding to an allosteric 
binding site on the γ-aminobutyric acid (GABA) A receptor. 
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3. Neuroendocrine Dysregulation and Mental Disorders after TBI 
Irrespective of severity of TBI, the vast majority of subjects report cognitive impairments and 
psychopathological symptoms, with attentional, memory, and executive deficits being the most 
frequent cognitive sequelae [26]. Chronic mental fatigue is a common disabling phenomenon in TBI 
subjects [27] and may reflect injury to the ventromedial prefrontal cortex [28]. Symptoms of major 
depression may be present in about a third of 91 subjects with TBI, of which about 75% exhibited 
comorbid anxiety and about 60% exhibited aggressive behavior [29]. Post-TBI patients also report 
reduced quality of sleep [30], which may contribute to their complaints of anxiety and depression. 
Traumatic brain injury is often accompanied by chronic neuroendocrine dysfunction due to pituitary 
insufficiency or “hypopituitarism”. Schneider et al. [31,32] reported at least one pituitary function 
anomaly in 56% of 78 TBI subjects; in a systematic review of 19 studies (1137 cases), the same 
authors reported hypopituitarism in about 28% of TBI subjects Schneider et al. [33]. 
Reduced anterior pituitary activity is commonly associated by dysregulation of anterior  
pituitary-dependent growth, thyroid, and GC hormone secretion [34], as well as antidiuretic hormone 
(ADH) [35]. While ADH deficiency may contribute to diabetes insipidus in some patients [36], it may 
also underpin hyponatremia, a serious complication of up to 33% of subjects who suffered TBI [35,37]. 
Given that TBI patients may suffer from multiple endocrine deficiencies [38,39], it is difficult to 
attribute particular cognitive and affective symptoms to disruption of a single hormone. In this regard, 
it is worth noting that TBI subjects may present with disparate cognitive and affective symptoms that 
may appear as general impairments. For example, hypopituitarism after TBI may be associated with 
poor life quality and higher rates of depression and fatigue [40]. This is better illustrated by the results 
reported by Popovic et al. [41], who observed reduced visual and verbal memory and visuo-constructive 
abilities, impaired executive function, and mild-to-moderate depressive symptoms among TBI patients 
with hypopituitarism (34% of a total of 67 patients who had suffered TBI within the last 12 months). 
Pavlovic et al. [42] found no association between GH deficiency and chronic cognitive impairments 
more than one year after TBI. In contrast, other authors reported an association between growth 
hormone insufficiency and persistent (≥12 months) impairments in attention and verbal memory [43] 
and, irrespective of severity of TBI, reductions in energy and emotional well-being, as well as 
increased fatigue and depressive symptomatology in a smaller number (18% of 44 subjects; [44]). In 
addition, León-Carrión et al. [45] reported impaired attention, memory and executive function and 
affective symptoms in patients with severe TBI who developed GH deficiency. 
The results of hypopituitarism on mental functions support the view that hormones play an 
important role for optimal functioning of brain systems involved in cognition and mood.  
Although cognition and mood were assessed directly in only a few studies, and despite the fact that 
dysfunctions differ with respect to frequencies as well as examined cognitive and affective domains, it 
is plausible to assume that all domains of cognition, i.e., attention, memory, and executive function, 
can be impaired. It is possible that endocrine dysfunction mainly affects regulatory mental processes; 
this would explain why executive components of cognition are mainly impaired, with secondary 
consequences for information processing, attention and memory. Although no data are available yet on 
specific effects of hypocortisolism, hypothyroidism, and diabetes insipidus in subjects with TBI, it 
seems reasonable to expect that TBI patients and subjects with respective hormonal dysfunction 
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without brain injury (see above) would show similar mental impairments. Evidence for this could be 
obtained by comparing mental functions in healthy subjects, and patients with hypopituitarism caused 
by TBI vs. all other causes. 
Perusal of the literature indicates that TBI-associated hypopituitarism mainly affects executive 
functions, with lesser effects on information processing, attention and memory systems. This is 
striking because memory difficulties appear to be the most frequent cognitive symptom in subjects 
with endocrine dysfunction, possibly because the hippocampus is a major target of GC and other 
hormones. On the other hand, it should be remarked that experiments in rodents have revealed that 
high GC levels disrupt executive components of memory by inducing atrophy in prefrontal areas [46]. 
In humans, a similar effect has been reported, but only for subjects with mild cognitive impairment 
(MCI), not for healthy elderly and subjects with Alzheimer disease [47]. 
Lastly, establishment of sequential/temporal cause-effect relationships between TBI, hypopituitarism 
(including the role of individual hormones) and behavioral impairments must await the development of 
suitable paradigms in animals; such studies will also facilitate deeper exploration of the cellular/neuroplastic 
mechanisms that underlie the hormone-mediated effects of TBI on mental functions. 
4. Growth Hormone (GH) Replacement for Mental Dysfunction after TBI 
In light of the strong evidence suggesting that TBI-induced impairments of mental function are 
causally related to injury-associated reductions in hormone secretion, it is reasonable to expect that 
hormone replacement therapy would partially or fully restore mental functions or, at the very least, 
facilitate post-injury rehabilitation. Indeed, promising results have been reported on the effects of 
hormone replacement in growth hormone-deficient subjects. For example, a pilot study by Maric et al. [48] 
found significantly improved verbal and visual memory and significantly reduced depressive and 
anxiety symptoms in six TBI patients with GH deficiency following six months of GH therapy. In a 
randomized placebo-controlled study of 23 TBI subjects with GH deficiency, High et al. [49] found 
significant improvements in overall mental speed after one year of GH replacement; however, the 
authors failed to observe treatment-associated changes in specific cognitive abilities such as memory 
and executive function. Similarly, Reimunde et al. [50] found a general improvement in cognition in a 
small placebo-controlled study (n = 11) on TBI subjects that had undergone GH therapy. Lastly, a 
randomized control study (23 GH-treated and 27 placebo-treated subjects that had suffered TBI > 5 years 
previously) found modest, but significant, improvements in overall mental speed and verbal memory 
effects of GH replacement [51]. 
GH therapy has proven to be effective in improving cognition and mood in other patient groups 
with hypopituitarism (e.g., [52,53]). However, the preliminary evidence of beneficial treatment effects 
of GH replacement for cognitive deficits in subjects with TBI is too weak to draw conclusions about 
efficacy and importantly, specificity. Although the literature reports improvements in a variety of 
cognitive domains (especially in mental speed), this does not necessarily exclude effects on specific 
domains (e.g., executive function and memory). Since GH deficiency represents probably the most 
common pituitary disorder after TBI [54], research on GH replacement in TBI subjects deserves 
priority. Nevertheless, it would be important to examine also the potential benefits of hormone 
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replacement for TBI patients displaying concomitant impairments of mental and adrenal, and/or 
thyroid function. 
5. Conclusions and Recommendations 
It becomes clear from the experimental and clinical data available, that hormones play an important 
role in maintaining optimal brain functioning in the adult. Subjects with endocrine dysfunction may 
exhibit mental disorders, spanning the cognitive, affective and/or behavioral domains.  
Notably, subjects with endocrine alterations show more global, unspecific cognitive dysfunction, with 
mental slowing and impaired executive regulatory process being dominant features; these can be 
alleviated by GH replacement. This observation fits with the idea of a final common pathway disorder, 
which is based on the premise that any type of dysfunction of the complex network underlying 
executive, regulatory components of cognition and mood may produce a similar pattern of disorders [55,56]. 
While more studies are needed to strengthen this view, support comes from the fact that frontal brain 
structures are relatively well endowed with hormone receptors [57]. 
Subjects with TBI frequently present with cognitive and affective disorders, but disentangling the 
causes of these (morphological injury vs. primary neuroendocrine dysfunction) remains a challenge. 
The evidence briefly reviewed here underscores the need for the identification and timely appropriate 
clinical management of hormone deficiencies, as well as for a comprehensive neuropsychological and 
psychopathological assessment in subjects with TBI. Likewise, the need for endocrine profiling and 
replacement in subjects with hypopituitarism deserves further attention, including the definition of 
criteria regarding indication of hormone replacement and evaluation of treatment efficacy (see [58]). 
The latter will require comprehensive cognitive and affective assessments of individuals using 
standardized and robust neuropsychological tests ([3,59]; cf. Tables 1 and 2). Together, these 
considerations will help develop appropriate strategies for therapeutic measures involving 
neuropsychological rehabilitation for TBI patients. 
Table 1. Mental domains and functional significance. 
Domains Functional Significance 
Attention  
Alertness (vigilance) preparedness to respond or act 
Information 
processing capacity speed and accuracy of information processing 
Sustained attention maintenance of attention at a given level for an extended period of time  
Divided attention simultaneous attention to two or more stimuli/actions  (prerequisite to perform concurrently two or more tasks) 
Spatial attention distribution of attention in space (global (parallel) processing, local processing) 
Memory  
Short-term memory recall (reproduction or recognition) of a limited number of stimuli  without further elaboration 
Working memory recall (reproduction or recognition) of a limited number of stimuli  with further elaboration 
Episodic memory memory for specific, personally experienced events in a given context  (time, place, etc.) 
Semantic memory memory for general or domain-specific knowledge or information 
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Table 1. Cont. 
Domains Functional Significance 
Verbal memory capacity to remember (reproduction or recognition) written or spoken material 
Visual memory capacity to remember (reproduction or recognition) visual images 
Executive function  
Planning mental outline of the steps required to perform a task or solve a problem 
Problem solving process by which individuals attempt to solve a complex task 
Cognitive flexibility objective appraisal and appropriate flexible action,  e.g., ability to change between visual or verbal stimuli or between actions 
Multi-tasking ability to perform more than one action/task at a time, requiring multiple information processing, working memory, divided attention, and monitoring of actions 
Affective state/mood any type of emotional state, associated with an emotional response bias  for days or weeks 
Table 2. Recommendations for a standardized assessment of cognition and affective 
state/mood (for a detailed and comprehensive description of assessment measures, see [60]). 
Domains Test(s) 
Premorbid intelligence Verbal IQ-scale of the WAIS-R; National Adult Reading Test (NART) 
Attention  
Alertness (vigilance) Reaction time with (phasic alertness) and  without warning signals (tonic alertness) 
Information processing capacity Trail Making Test (TMT) A 
Sustained attention Continued Performance Tests (CPT) 
Divided attention Test (PASAT) Stroop Test; Symbol Digit Modalities Test (SDMT);  Paced Auditory Serial Addition 
Spatial attention cancellation tests; visual search tests 
Memory  
Short-term memory digit span forward; block tapping forward 
Working memory digit span backward; block tapping backward  
Semantic memory  
Verbal memory Auditory Verbal Learning tests; story recall (Logical Memory; WMS III/IV) 
Visual memory Visual reproductions (WMS III/IV); Camden Memory tests 
Executive function  
Planning/problem solving Raven’s Coloured Progressive Matrices (RCPM);  Porteus Maze Test; Tower of London Test 
Cognitive flexibility Trail making Test (TMT) B; Wisconsin Card Sorting Test (WCST);  verbal fluency tests (COWAT) 
Multi-tasking Symbol Digit Modalities Test (SDMT);  Paced Auditory Serial Addition Test (PASAT); Stroop Tests 
Affective state/mood Hospital anxiety and depression scale (HADS);  Geriatric depression scale (GDS) 
Given the multifactorial nature of TBI, it is imperative that an interdisciplinary approach is 
developed to improve clinical outcomes [59,60]. However, management and prognosis for patients 
with TBI-induced hypopituitarism are confounded by “the marked variability in type, location and 
degree of pathological changes following a TBI, as well as the equally ubiquitous variability in  
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pre-morbid organic and psychological functioning …” [60]. This explains the present equivocal 
conclusions regarding the impact of TBI-related hormone deficiency on mental function and chronic 
complaints of fatigue [61–63]. 
Author Contributions 
Both authors contributed equally to the manuscript. 
Conflicts of Interest 
The authors declare no conflict of interest 
References 
1. Roebuck-Spencer, T.; Cernich, A. Epidemiology and societal impact of traumatic brain injury.  
In Handbook on the Neuropsychology of Traumatic Brain Injury; Sherer, M., Sander, A.M., Eds.; 
Springer: New York, NY, USA, 2014; pp. 3–23. 
2. Shallice, T.; Cooper, R. The Organization of Mind; Oxford University Press: Oxford, UK, 2011. 
3. Erlanger, D.M.; Kutner, K.C.; Jacobs, A.R. Hormones and cognition: Current concepts and issues 
in neuropsychology. Neuropsychol. Rev. 1999, 9, 175–207. 
4. Griffen J.; Hanks, R. Cognitive and behavioral outcomes from traumatic brain injury.  
In Handbook on the Neuropsychology of Traumatic Brain Injury; Sherer, M., Sander, A.M., Eds.; 
Springer: New York, NY, USA, 2014; pp. 25–45. 
5. Dikmen, S.S.; Bombardier, C.H.; Machamer, J.E.; Fann, J.R.; Temkin, N.R. Natural history of 
depression in traumatic brain injury. Arch. Phys. Med. Rehabil. 2004, 85, 1457–1464. 
6. Van Reekum, R.; Cohen, T.; Wong, J. Can traumatic brain injury cause psychiatric disorders?  
J. Neuropsychiatry Clin. Neurosci. 2000, 12, 316–327. 
7. Bigler, E.D. The lesion(s) in traumatic brain injury: Implications for clinical neuropsychology. 
Arch. Clin. Neuropsychol. 2001, 16, 95–131. 
8. Kraus, M.F.; Susmaras, T.; Caughlin, B.P.; Walker, C.J.; Sweeney, J.A.; Little, D.M.  
White matter integrity and cognition in chronic traumatic brain injury: A diffusion tensor imaging 
study. Brain 2007, 130, 2508–2519. 
9. Waas, J.A.H.; Reddy, R. Growth hormone and memory. J. Endocrinol. 2010, 207, 125–126. 
10. Webb, E.A.; O’Reilly, M.A.; Clayden, J.D.; Seunarine, K.K.; Chong, W.K.; Dale, N.; Salt, A.; 
Clark, C.A.; Dattani, M.T. Effect of growth hormone deficiency on brain structure, motor function 
and cognition. Brain 2012, 135, 216–227. 
11. Nyberg, F.; Hallberg, M. Growth hormone and cognitive function. Nat. Rev. Endocrinol. 2013, 9, 
357–365. 
12. Roriz-Cruz, M.; Rosset, I.; Wada, T.; Sakagami, T.; Ishine, M.; De Sa Roriz-Filho, J.; Cruz, T.R.; 
Hosseinkhani, M.; Rodrigues, R.P.; Sudoh, S.; et al. Cognitive impairment and frontal-subcortical 
geriatric syndrome are associated with metabolic syndrome in a stroke-free population.  
Neurobiol. Aging 2007, 28, 1723–1736. 
13. Kodl, C.T.; Seaquist, E.R. Cognitive dysfunction and diabetes mellitus. Endocr. Rev. 2008, 29, 494–511. 
J. Clin. Med. 2015, 4 1059 
 
 
14. Bruehl, H.; Wolf, O.T.; Sweat, V.; Tirsi, A.; Richardson, St.; Convit, A. Modifiers of cognitive 
function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. 
Brain Res. 2009, 1280, 186–194. 
15. Prinz, P.N.; Scanlan, J.N.; Vitaliano, P.P.; Moe, K.E.; Borson, S.; Toivola, B.; Merriam, G.R.; 
Larsen, L.H.; Reed, H.L. Thyroid hormones: Positive relationships with cognition in healthy, 
euthyroid older men. J. Gerontol. A Biol. Sci. Med. Sci. 1999, 54, M111–M116. 
16. Rivas, M.; Naranjo, J.R. Thyroid hormones, learning and memory. Genes Brain Behav. 2007, 1, 40–44. 
17. Samuels, M.H. Cognitive function in untreated hypothyroidism and hyperthyroidism.  
Curr. Opin. Endocrinol. Diabetes Obes. 2008, 15, 429–433.  
18. Hall, R.C. Psychiatric effects of thyroid hormone disturbance. Psychosomatics 1983, 24, 7–18. 
19. Shively, C.A.; Bethea, C.L. Cognition, mood disorders, and sex hormones. ILAR J. 2004, 45, 189–199. 
20. Luine, V.N. Sex steroids and cognitive function. J. Endocrinol. 2008, 20, 8665–8872. 
21. Gallagher, P.; Reid, K.S.; Ferrier, I.N. Neuropsychological functioning in health and mood 
disorder: Modulation of glucocorticoids and their receptors. Psychoneuroendocrinology 2009, 34, 
S196–S207. 
22. Joels, M. Impact of glucocorticoids on brain function: Relevance for mood disorders. 
Psychoneuroendocrinology 2011, 36, 406–414. 
23. Lupien, S.J.; McEwen, B.S. The acute effects of corticosteroids on cognition: Integration of 
animal and human model studies. Brain Res. Rev. 1997, 24, 1–27. 
24. Reppermund, S.; Zihl, J.; Lucae, S.; Horstmann, S.; Kloiber, S.; Holsboer, F.; Ising, M.  
Persistent cognitive impairment in depression: The role of psychopathology and altered 
hypothalamic-pituitary-adrenocortical (HPA) system regulation. Biol. Psychiatry 2007, 62, 400–406. 
25. Patel, P.D.; Lopez, J.F.; Lyons, D.M.; Burke, S.; Wallace, M.; Schatzberg, A.F.  
Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain.  
J. Psychiatr. Res. 2000, 34, 383–392. 
26. Ponsford, J.L.; Downing, M.G.; Olver, J.; Ponsford, M.; Acher, R.; Carty, M.; Spitz, G. 
Longitudinal follow-up of patients with traumatic brain injury: Outcome at two, five, and ten 
years post-injury. J. Neurotrauma 2014, 31, 64–77.  
27. Schonberger, M.; Herrberg, M.; Ponsford, J. Fatigue as a consequence, not a consequence of 
depression and daytime sleepiness: A cross-lagged analysis. J. Head Trauma. Rehabil. 2014, 29, 
427–431. 
28. Pardini, M.; Krueger, F.; Ramont, V.; Grafman, J. Ventromedial prefrontal cortex modulates 
fatigue after penetrating traumatic brain injury. Neurology 2010, 74, 749–754. 
29. Jorge, R.E.; Robinson, R.E.; Moser, D.; Tateno, A.; Crespo-Facorro, B.; Arndt, St. Major 
depression following traumatic brain injury. Arch. Gen. Psychiatry 2004, 61, 42–50. 
30. Ponsford, J.; Parcell, D.L.; Sinclair, K.L.; Roper, M.; Rajaratnam, S.M.W. Changes in sleep 
patterns following traumatic brain injury: A controlled study. Neurorehabilitation Neural Repair 
2013, 27, 613–621. 
31. Schneider, H.J.; Schneider, M.; Saller, B.; Petersenn, S.; Uhr, M.; Husemann, B.; von Rosen, F.; 
Stalla, G.K. Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain 
injury. Eur. J. Endocrinol. 2006, 154, 165–259. 
J. Clin. Med. 2015, 4 1060 
 
 
32. Schneider, M.; Schneider, H.J.; Yassouridis, A.; Saller, B.; von Rosen, F.; Stalla, G.K.  
Predictors of anterior pituitary insufficiency after traumatic brain injury. Clin. Endocrinol. (Oxf.) 
2008, 68, 206–212. 
33. Schneider, H.J.; Kreitschmann-Andermahr, I.; Ghigo, E.; Stalla, G.K.; Agha, A. 
Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid 
hemorrhage: A systematic review. J. Am. Med. Ass. 2007, 298, 1429–1438. 
34. Powner, D.J.; Boccalandro, C.; Alp, M.S.; Vollmer, D.G. Endocrine failure after traumatic brain 
injury in adults. Neurocrit Care 2006, 5, 61–70. 
35. Born, J.D.; Hans, P.; Smitz, S.; Legros, J.J.; Kay, S. Syndrome of inappropriate secretion of 
antidiuretic hormone after severe head injury. Surg. Neurol. 1985, 23, 383–387. 
36. Tsagarakis, S.; Tzanela, M.; Dimopoulou, I. Diabetes insipidus, secondary hypoadrenalism and 
hypothyroidism after traumatic brain injury: Clinical implications. Pituitary 2005, 8, 154–251. 
37. Moro, N.; Katayama, Y.; Igarashi, T.; Mori, T.; Kawamata, T.; Kojima, J. Hyponatremia in 
patients with traumatic brain injury: Mechanism, and response to sodium to sodium 
supplementation or retention therapy with hydrocortisone. Surg. Neurol. 2005, 68, 387–393. 
38. Makulski, D.D.; Taber, K.H.; Chiou-Tan, F.Y. Neuroimaging in posttraumatic hypopituitarism.  
J. Comput. Assist. Tomogr. 2008, 32, 324–328. 
39. Lieberman, S.A.; Oberoi, A.L.; Gilkison, C.R.; Masel, B.E.; Urban, R.J. Prevalence of 
neuroendocrine dysfunction in patients recovering from traumatic brain injury. J. Clin. Endocrinol. 
Metab. 2001, 86, 2752–2756. 
40. Ulfarsson, T.; Gudnason, G.A.; Rosen, T.; Blomstrand, C.; Sunnerhagen, K.S.; Lundgren-Nilsson, A.; 
Nilsson, M. Pituitary function and functional outcome in adults after severe traumatic brain injury: 
The long-term perspective. J. Neurotrauma 2013, 30, 271–280. 
41. Popovic, V.; Pekic, S.; Pavlovic, D.; Maric, N.; Jasovic-Gasic, M.; Djurovic, B.;  
Medic-Stojanska, M.; Zivkovic, V.; Stojanovic, M.; Doknic, M.; et al. Hypopituitarism as a 
consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities 
and mental stress. J. Endocrinol. Investig. 2004, 27, 1048–1054. 
42. Pavlovic, D.; Pekic, S.; Stojanovic, M.; Zivkovic, V.; Djurovic, B.; Jovanovic, V.; Miljic, N.; 
Medic-Stojanska, M.; Doknic, M.; Miljic, D.; et al. Chronic cognitive sequelae after traumatic 
injury are not related to growth hormone deficiency in adults. Eur. J. Neurol. 2010, 17, 696–702. 
43. Moreau, O.K.; Yollin, E.; Merlen, E.; Daveluy, W.; Rousseaux, M. Lasting pituitary hormone 
deficiency after traumatic brain injury. J. Neurotrauma 2012, 29, 81–89. 
44. Kelly, D.F.; McArthur, D.L.; Levin, H.; Swimmer, S.; Dusick, J.R.; Cohan, P.; Wang, C.; 
Swerdloff, R. Neurobehavioral and quality of life changes associated with growth hormone 
insufficiency after complicated mild, moderate, or severe traumatic brain injury. J. Neurotrauma 
2006, 23, 928–942. 
45. León-Carrión, J.; Leal-Cerro, A.; Murillo Cabezas, F.; Madrazo Atutxa, A.; García Gomez, G.; 
Flores A.; Rincón Ferrari, M.D.; Domínguez-Morales, M. Cognitive deterioration due to GH 
deficiency in patients with traumatic brain injury: A preliminary report. Brain Injury 2007, 21, 
871–875. 
46. Cerqueira, J.J.; Mailliet, F.; Almeida, O.F.X.; Jay, T.M.; Sousa, N. The prefrontal cortex as a key 
target of the maladaptive response to stress. J. Neurosci. 2007, 27, 2781–2787. 
J. Clin. Med. 2015, 4 1061 
 
 
47. Souza-Talarico, J.N.; Chaves, E.C.; Lupien, S.J.; Nitrini, R.; Caramelli, P. Relationship between 
cortisol levels and memory performance may be modulated by the presence or absence of 
cognitive impairment: Evidence from healthy elderly, mild cognitive impairment and Alzheimer’s 
disease subjects. J. Alzheimers Dis. 2010, 19, 839–848. 
48. Maric, N.P.; Doknic, M.; Pavlovic, D.; Pekic, S.; Stojanovic, M.; Jasovic-Gasic, M.; Popovic, V. 
Psychiatric and neuropsychological changes in growth hormone-deficient patients with traumatic 
brain injury in response to growth hormone therapy. J. Endocrinol. Investig. 2010, 3, 770–775. 
49. High, E.M.; Briones-Galang, M.; Clark, J.A.; Gilkison, C.; Mossberg, K.A., Zgaljardic, D.J.; 
Masel, B.E.; Urban, R.J. Effect of growth hormone therapy on cognition after traumatic brain 
injury. J. Neurotrauma 2010, 27, 1565–1575. 
50. Reimunde, P.; Quintana, A.; Castanon, B.; Casteleiro, N.; Vilarnovo, Z.; Otero, A.; Devesa, A.; 
Otero-Cepeda, X.L.; Devesa, J. Effects of growth hormone (GH) replacement and cognitive 
rehabilitation in patients with cognitive disorders after traumatic brain injury. Brain Injury 2011, 
25, 65–73. 
51. Moreau, O.K.; Cortel-Rudelli, C.; Yollin, E.; Merlen, E.; Daveluy, W.; Rousseaux, M.  
Growth replacement therapy in patients with traumatic brain injury. J. Neurotrauma 2013, 30, 
998–1006. 
52. Oertel, H.; Schneider, H.J.; Stalla, G.K.; Holsboer, F.; Zihl, J. The effect of growth hormone 
substitution on cognitive performance in adult patients with hypopituitarism. Psychoneuroendocrinology 
2004, 29, 839–850. 
53. Maki, P.M.; Sunderman, E. Hormone therapy and cognitive function. Hum. Reprod. Update 2009, 
15, 667–681.  
54. Popovic, V. GH deficiency as the most common pituitary defect after TBI: Clinical implications. 
Pituitary 2005, 8, 239–243. 
55. Keefe, R.S.E. The contribution of neuropsychology to psychiatry. Am. J. Psychiatry 1995, 152, 6–15. 
56. Zihl, J.; Reppermund, S.; Thum, S.; Unger, K. Neuropsychological profiles in MCI and 
depression: Differential cognitive dysfunction patterns or similar final common pathway disorder? 
J. Psychiatr. Res. 2010, 44, 647–654. 
57. Allen Human Brain Atlas; Allen Institute for Brain Science: Seattle, WA, USA, 2014.  
Available online: http://human.brain-map.org/ (accessed on 16 April 2015). 
58. Ghigo, E.; Masel, B.; Aimaretti, G.; Leon-Carrion, J.; Casanueva, F.F.; Dominguez-Morales, M.R.; 
Elovioc, E.; Stalla, G.; Thompson, C.; Urban, R. Consensus guidelines on screening for 
hypopituitarism following traumatic brain injury. Brain Injury 2005, 19, 711–724. 
59. Bergquist, T.F.; Yutsis, M.; Micklewright, J.L. Comprehensive assessment. In Handbook on the 
Neuropsychology of Traumatic Brain Injury; Sherer, M., Sander, A.M., Eds.; Springer:  
New York, NY, USA, 2014; pp. 77–93. 
60. Lezak, M.D.; Howieson, D.B.; Bigler, E.D.; Tranel, D. Neuropsychological assessment, 5th ed.; 
Oxford University Press: Oxford, UK, 2012. 
61. Behan, L.A.; Phillips, J.; Thompson, C.J.; Agha, A. Neuroendocrine disorders after traumatic 
brain injury. J. Neurol. Neurosurg. Psychiatry 2008, 79, 753–759. 
J. Clin. Med. 2015, 4 1062 
 
 
62. Englander, J.; Bushnik, T.; Oggins, J.; Katznelson, L. Fatigue after traumatic brain injury: 
Association with neuroendocrine, sleep, depression, and other factors. Brain Injury 2010, 24, 
1379–1388. 
63. Bushnik, T.; Englander, J.; Katznelson, L. Fatigue after TBI: Association with neuroendocrine 
abnormalities. Brain Injury 2007, 21, 559–566. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
